Expression of Caveolin-1 (CAV1), PAX2 and Survivin (SURV) in Clear Cell Renal Cell Carcinoma (CRCC): No Evidence for Prognostic Significance

被引:0
|
作者
Kankaya, D. [1 ]
Kiremitci, S. [1 ]
Tulunay, O. [1 ]
Baltaci, S. [1 ]
机构
[1] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
884
引用
收藏
页码:199A / 199A
页数:1
相关论文
共 50 条
  • [31] Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma
    Luu, Van-Duc
    Boysen, Gunther
    Struckmann, Kirsten
    Casagrande, Silvia
    von Teichman, Adriana
    Wild, Peter J.
    Sulser, Tullio
    Schraml, Peter
    Moch, Holger
    CLINICAL CANCER RESEARCH, 2009, 15 (10) : 3297 - 3304
  • [32] PAX2 - a new target of the pVHL/HIF cascade in human clear-cell renal cell carcinoma
    Struckmann, K.
    Thoma, C.
    Frew, I.
    Krek, W.
    Von Teichman, A.
    Steu, S.
    Storz, M.
    Boysen, G.
    Schraml, P.
    Moch, H.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 287 - 287
  • [33] Association of Caveolin-1 Genotypes with Renal Cell Carcinoma Risk in Taiwan
    Chang, Wen-Shin
    Tsai, Chia-Wen
    Wang, Shu-Ming
    Wang, Shyi-Wu
    Wu, Hsi-Chin
    Ji, Hong-Xue
    Lin, Chih-Hsueh
    Wang, Zhi-Hong
    Chou, Jou-Chun
    Bau, Da-Tian
    Wang, Paulus S.
    CHINESE JOURNAL OF PHYSIOLOGY, 2014, 57 (04): : 220 - 226
  • [34] Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma (vol 358, pg 269, 2017)
    Ruan, HaiLong
    Li, Xiang
    Yang, HongMei
    Song, ZhengShuai
    Tong, JunWei
    Cao, Qi
    Wang, KeShan
    Xiao, Wen
    Xiao, HaiBin
    Chen, XuanYu
    Xu, GuangHua
    Bao, Lin
    Xiong, ZhiYong
    Yuan, ChangFei
    Liu, Lei
    Qu, Yan
    Hu, WenJun
    Gao, YaoYing
    Ru, ZeYuan
    Chen, Ke
    Zhang, XiaoPing
    EXPERIMENTAL CELL RESEARCH, 2018, 362 (01) : 244 - 244
  • [35] Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma
    Kuroda, Naoto
    Agatsuma, Yoshiko
    Tamura, Masato
    Martinek, Petr
    Hes, Ondrej
    Michal, Michal
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (02): : 2131 - 2138
  • [36] Progressive loss of retinal arteriolar smooth muscle cells (SMCs) with aging and caveolin-1 (Cav1) depletion: Assessing the importance of endothelial cell (EC)-Cav1 in retinal SMC maintenance
    Gurley, Jami
    Standifer, Nick
    Hargis, Elizabeth A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [37] Laminin β1 and β2 Expression in Vasculature of Clear Cell Renal Cell Carcinoma
    Chang, E. E.
    Luthringer, D. J.
    dePeralta-Venturina, M.
    Babaidorabad, N.
    Ljubimov, A. V.
    Ljubimova, J. Y.
    Amin, M. B.
    LABORATORY INVESTIGATION, 2013, 93 : 200A - 200A
  • [38] Laminin β1 and β2 Expression in Vasculature of Clear Cell Renal Cell Carcinoma
    Chang, E. E.
    Luthringer, D. J.
    dePeralta-Venturina, M.
    Babaidorabad, N.
    Ljubimov, A. V.
    Ljubimova, J. Y.
    Amin, M. B.
    MODERN PATHOLOGY, 2013, 26 : 200A - 200A
  • [39] Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
    Xia, Yu
    Liu, Li
    Bai, Qi
    Long, Qilai
    Wang, Jiajun
    Xi, Wei
    Xu, Jiejie
    Guo, Jianming
    ONCOLOGY LETTERS, 2017, 14 (05) : 5791 - 5800
  • [40] Prognostic significance of MALAT1 in clear cell renal cell carcinoma based on TCGA and GEO
    Liu, Kai
    Gao, Yingxue
    Zhang, Quanwu
    MEDICINE, 2023, 102 (37) : E35249